Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Devices
MedTech
SetPoint nets $140M following FDA neuromod approval in RA
Shortly after an FDA green light, SetPoint scored $140 million in funding to juice the roll out of its neuromod implant for rheumatoid arthritis.
Conor Hale
Aug 11, 2025 11:30am
10x Genomics scoops up Scale Bio for single-cell analysis
Aug 8, 2025 12:22pm
Apreo Health nets $130M to develop lung scaffold for emphysema
Aug 8, 2025 11:30am
Investor syndicate takes majority stake in HistoSonics
Aug 7, 2025 1:16pm
FTC aims to stop Edwards' acquisition of JenaValve
Aug 7, 2025 11:33am
Orchestra BioMed scores $111M, backed by Medtronic, Ligand
Aug 5, 2025 3:41pm
